The reagent kit is designed to diagnose respiratory viral infection caused by the SARS-CoV-2 coronavirus. RNA isolation from clinical material is not required.
The kit is designed for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus and influenza A and B viruses.
It is intended for use in patients with clinical symptoms of a viral disease with a suspected infection caused by Chikungunya, Zika, Dengue viruses.
The kit is intended for diagnostics of the respiratory viral infection caused by the SARS-CoV-2 coronavirus.
The kit is designed for detection and differentiation of the hepatitis B, C and D viruses in patients with suspected infection.
The kit is designed for quantitative detection of the hepatitis B virus DNA in patients with suspected infection and determination of viral load in patients with the detected hepatitis B virus to choose an appropriate therapy and evaluate its effectiveness.